The need for establishing best practices and gold standards in psychedelic medicine.
Journal of Affective Disorders July 1, 2023 Allison A. Feduccia, Gabby Agin-Liebes, Collin M Price et al. 38 citations
Psychedelic substances are under investigation in several drug development programs. Controlled clinical trials are providing evidence for safe and effective use of psychedelic therapies for treating mental health conditions. With the anticipated FDA approval of MDMA-assisted therapy for posttraumatic stress disorder in 2023 and psilocybin therapy for depression disorders soon after, now is the...